Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898053 · ClinicalTrials.gov registry record
Study of Tumor Samples From Patients With Ewing Sarcoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 200
- Enrollment target
NCT00898053: Completed study, sponsored by Children's Oncology Group.
NCT00898053 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898053 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This laboratory study is looking at tumor samples from patients with Ewing sarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-09 |
| Est. Completion | 2016-05 |
What the finished NCT00898053 record still lists
NCT00898053 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT00898053 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00898053 about?
NCT00898053 is a clinical study titled "Study of Tumor Samples From Patients With Ewing Sarcoma". This laboratory study is looking at tumor samples from patients with Ewing sarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
What is the current status of trial NCT00898053?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2008-09. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00898053?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00898053?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia